COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,495 Articles (22,862 medRxiv, 8,633 bioRxiv)

Most recent first Previous |  Page 5: Articles 41-50  | Next

Transmission dynamics of the COVID-19 pandemic across the emerging variants in mainland China: a hypergraph-based spatiotemporal modeling study
Wang, Y., WANG, D., Lau, Y. C., Du, Z., Cowling, B. J., Zhao, Y., Ali, S. T.
10.64898/2026.04.16.26351004 — Posted: 2026-04-17
SARS-CoV-2 neutralising antibody profiles reveal variant specific antibody dynamics and regional differences in infection histories in Malawi
McCormack, M. J., Banda, L., Kasenda, S., Hughes, E. C., Crampin, A. C., Amoah, A. S., Read, J. M., Ho, A., Willett, B. J., Hay, J. A.
10.64898/2026.04.16.26351029 — Posted: 2026-04-17
Repeated SARS-CoV-2 Antigenic Exposures from Prior Vaccinations and Infections Demonstrate Limits of Antibody Durability and Breadth Against Newer Variants
WANG, W., Goguet, e., Lusvarghi, S., Paz, S., Shrestha, L., Vassell, R., Pollett, S., Mitre, E., Weiss, C. D.
10.64898/2026.04.15.718804 — Posted: 2026-04-16
SPLIT: Safety Prioritization for Long COVID Drug Repurposing via a Causal Integrated Targeting Framework
Pinero, S. L., Li, X., Lee, S. H., Liu, L., Li, J., Le, T. D.
10.64898/2026.04.12.26350701 — Posted: 2026-04-16
Effectiveness of 2025-2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19 Related Hospitalizations and Medically-Attended COVID-19 Among Adults Aged >= 65 years in the United States
Vicic, N., Bogdanov, A., Hensler, H., Ryan, T., Zeng, N., Beck, E., Patry, E., Bonafede, M., Araujo, A. B., Wilson, A.
10.64898/2026.04.13.26350772 — Posted: 2026-04-16
Cognitive Profiling and Validation of a Digital Cognitive Assessment Tool in Post-COVID-19 Condition: Protocol for a Single-Center, Cross-Sectional Study (DigiCog Study)
Lacomba-Arnau, E., Da Rocha Oliveira, R., Monteiro, S., Pauly, C., Vaillant, M., Celebic, A., Bulaev, D., Fischer, A., Fagherazzi, G., Fernandez, G., Shulz, M., Perquin, M.
10.64898/2026.04.14.26350862 — Posted: 2026-04-16
Mechanistic insights into the association and activation of the SARS-CoV-2 2'-O-Methyltransferase (NSP16)
Ma, H., Brace, A., Lemus, M. R., Chennubhotla, S. C., Satchell, K. J., Ramanathan, A.
10.64898/2026.04.15.718757 — Posted: 2026-04-16
Tracing cell communication programs across conditions at single cell resolution with CCC-RISE
Ramirez, A., Thomas, N., Calabrese, D. R., Greenland, J. R., Meyer, A. S.
10.64898/2026.04.14.718551 — Posted: 2026-04-15
Risk of Post-acute Symptoms and Conditions After SARS-CoV-2 Compared to Other Respiratory Viral Infections: A Systematic Review and Meta-Analysis
Pinto, T. F., Santoro, A., Oliveira, A. L. G., Tavares, T. S., Almeida, A., Incardona, F., Marchetti, G., Cozzi-Lepri, A., Pinto, J., Caporali, J. F. M.
10.64898/2026.04.11.26350682 — Posted: 2026-04-13
Classifying and Differentiating Individuals with Respiratory Syncytial Virus, Influenza, and COVID-19 Cases in OpenSAFELY
Prestige, E., Warren-Gash, C., Quint, J. K., Evans, D., Costello, R. E., Mehrkar, A., Bacon, S., Goldacre, B., Barley-McMullen, S., Yameen, F., Shah, P., Natt, M., Alder, Y., Hulme, W., Parker, E. P. K., Eggo, R. M.
10.64898/2026.04.09.26350495 — Posted: 2026-04-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).